CN114748399A - Plant anti-wrinkle cosmetic cream and preparation method thereof - Google Patents
Plant anti-wrinkle cosmetic cream and preparation method thereof Download PDFInfo
- Publication number
- CN114748399A CN114748399A CN202210309701.8A CN202210309701A CN114748399A CN 114748399 A CN114748399 A CN 114748399A CN 202210309701 A CN202210309701 A CN 202210309701A CN 114748399 A CN114748399 A CN 114748399A
- Authority
- CN
- China
- Prior art keywords
- parts
- weight
- oil palm
- palm fruit
- weighing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000001153 anti-wrinkle effect Effects 0.000 title claims abstract description 38
- 239000008278 cosmetic cream Substances 0.000 title claims abstract description 23
- 238000002360 preparation method Methods 0.000 title abstract description 10
- 241000512897 Elaeis Species 0.000 claims abstract description 45
- 235000001950 Elaeis guineensis Nutrition 0.000 claims abstract description 45
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 45
- 229940016667 resveratrol Drugs 0.000 claims abstract description 37
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 claims abstract description 34
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 claims abstract description 34
- 235000021283 resveratrol Nutrition 0.000 claims abstract description 34
- 241000196324 Embryophyta Species 0.000 claims abstract description 31
- 239000002502 liposome Substances 0.000 claims abstract description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 17
- 239000006071 cream Substances 0.000 claims abstract description 11
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 11
- 239000002994 raw material Substances 0.000 claims abstract description 9
- 239000002738 chelating agent Substances 0.000 claims abstract description 6
- 239000003974 emollient agent Substances 0.000 claims abstract description 6
- 239000002562 thickening agent Substances 0.000 claims abstract description 6
- 230000003796 beauty Effects 0.000 claims abstract description 5
- 238000005303 weighing Methods 0.000 claims description 38
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 35
- 239000000203 mixture Substances 0.000 claims description 31
- 239000000284 extract Substances 0.000 claims description 30
- 238000003756 stirring Methods 0.000 claims description 23
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 claims description 20
- 239000000243 solution Substances 0.000 claims description 14
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims description 14
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 12
- 239000006185 dispersion Substances 0.000 claims description 12
- 238000001914 filtration Methods 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 11
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 claims description 10
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 10
- 229960000541 cetyl alcohol Drugs 0.000 claims description 10
- 238000010438 heat treatment Methods 0.000 claims description 10
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 claims description 9
- 238000004140 cleaning Methods 0.000 claims description 9
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 8
- YPFDHNVEDLHUCE-UHFFFAOYSA-N propane-1,3-diol Chemical compound OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 claims description 8
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 claims description 7
- 239000002244 precipitate Substances 0.000 claims description 7
- 230000002829 reductive effect Effects 0.000 claims description 7
- 238000002791 soaking Methods 0.000 claims description 7
- 229940032094 squalane Drugs 0.000 claims description 7
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 claims description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 6
- 229920000053 polysorbate 80 Polymers 0.000 claims description 6
- 239000005457 ice water Substances 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 5
- 229940075507 glyceryl monostearate Drugs 0.000 claims description 4
- 239000004519 grease Substances 0.000 claims description 4
- 239000011259 mixed solution Substances 0.000 claims description 4
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 claims description 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 2
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 2
- 229920002125 Sokalan® Polymers 0.000 claims description 2
- 229960001631 carbomer Drugs 0.000 claims description 2
- 229960005150 glycerol Drugs 0.000 claims description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 2
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 2
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 2
- 238000000605 extraction Methods 0.000 claims 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 abstract description 6
- 230000003712 anti-aging effect Effects 0.000 abstract description 6
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 abstract description 4
- 229940045997 vitamin a Drugs 0.000 abstract description 3
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 abstract description 2
- 235000014113 dietary fatty acids Nutrition 0.000 abstract description 2
- 229930195729 fatty acid Natural products 0.000 abstract description 2
- 239000000194 fatty acid Substances 0.000 abstract description 2
- 150000004665 fatty acids Chemical class 0.000 abstract description 2
- 239000004005 microsphere Substances 0.000 abstract description 2
- 230000003647 oxidation Effects 0.000 abstract description 2
- 238000007254 oxidation reaction Methods 0.000 abstract description 2
- 230000002195 synergetic effect Effects 0.000 abstract description 2
- 235000019155 vitamin A Nutrition 0.000 abstract description 2
- 239000011719 vitamin A Substances 0.000 abstract description 2
- 230000037303 wrinkles Effects 0.000 description 25
- 210000003491 skin Anatomy 0.000 description 22
- 239000000047 product Substances 0.000 description 18
- 230000000694 effects Effects 0.000 description 15
- 150000003254 radicals Chemical class 0.000 description 13
- 102000008186 Collagen Human genes 0.000 description 10
- 108010035532 Collagen Proteins 0.000 description 10
- 229920001436 collagen Polymers 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- 239000004480 active ingredient Substances 0.000 description 9
- 108010014258 Elastin Proteins 0.000 description 8
- 102000016942 Elastin Human genes 0.000 description 8
- 230000032683 aging Effects 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 8
- 239000002537 cosmetic Substances 0.000 description 8
- 229920002549 elastin Polymers 0.000 description 8
- 230000008439 repair process Effects 0.000 description 7
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 6
- 210000004207 dermis Anatomy 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 5
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 5
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 5
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 5
- 102000002274 Matrix Metalloproteinases Human genes 0.000 description 5
- 108010000684 Matrix Metalloproteinases Proteins 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 210000002615 epidermis Anatomy 0.000 description 5
- 210000002744 extracellular matrix Anatomy 0.000 description 5
- 229940088594 vitamin Drugs 0.000 description 5
- 229930003231 vitamin Natural products 0.000 description 5
- 235000013343 vitamin Nutrition 0.000 description 5
- 239000011782 vitamin Substances 0.000 description 5
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 102000016387 Pancreatic elastase Human genes 0.000 description 4
- 108010067372 Pancreatic elastase Proteins 0.000 description 4
- 206010051246 Photodermatosis Diseases 0.000 description 4
- 241000408907 Xanthoceras Species 0.000 description 4
- 230000005856 abnormality Effects 0.000 description 4
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 4
- 230000002500 effect on skin Effects 0.000 description 4
- 229940088598 enzyme Drugs 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 210000002950 fibroblast Anatomy 0.000 description 4
- 229920002674 hyaluronan Polymers 0.000 description 4
- 229960003160 hyaluronic acid Drugs 0.000 description 4
- 239000003112 inhibitor Substances 0.000 description 4
- 230000008845 photoaging Effects 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 230000009759 skin aging Effects 0.000 description 4
- 238000013112 stability test Methods 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 102000003893 Histone acetyltransferases Human genes 0.000 description 3
- 108090000246 Histone acetyltransferases Proteins 0.000 description 3
- 206010020751 Hypersensitivity Diseases 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 206010070834 Sensitisation Diseases 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 229940119170 jojoba wax Drugs 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 229960003966 nicotinamide Drugs 0.000 description 3
- 239000011570 nicotinamide Substances 0.000 description 3
- 235000005152 nicotinamide Nutrition 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 230000008313 sensitization Effects 0.000 description 3
- 230000037394 skin elasticity Effects 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 235000019165 vitamin E Nutrition 0.000 description 3
- 239000011709 vitamin E Substances 0.000 description 3
- 230000037373 wrinkle formation Effects 0.000 description 3
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 description 2
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 2
- 229940035437 1,3-propanediol Drugs 0.000 description 2
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 2
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 2
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 2
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 2
- 229920001503 Glucan Polymers 0.000 description 2
- 102000006947 Histones Human genes 0.000 description 2
- 108010033040 Histones Proteins 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 2
- XJLXINKUBYWONI-NNYOXOHSSA-N NADP zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-NNYOXOHSSA-N 0.000 description 2
- 102000016611 Proteoglycans Human genes 0.000 description 2
- 108010067787 Proteoglycans Proteins 0.000 description 2
- 102000005876 Tissue Inhibitor of Metalloproteinases Human genes 0.000 description 2
- 108010005246 Tissue Inhibitor of Metalloproteinases Proteins 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 230000021736 acetylation Effects 0.000 description 2
- 238000006640 acetylation reaction Methods 0.000 description 2
- 229960005305 adenosine Drugs 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 229940106189 ceramide Drugs 0.000 description 2
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000000084 colloidal system Substances 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 238000005286 illumination Methods 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 229960003471 retinol Drugs 0.000 description 2
- 235000020944 retinol Nutrition 0.000 description 2
- 239000011607 retinol Substances 0.000 description 2
- 230000037380 skin damage Effects 0.000 description 2
- 229940096998 ursolic acid Drugs 0.000 description 2
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- FDHNLHLOJLLXDH-JIYHLSBYSA-N (e)-3-(3-hydroxy-4-methoxyphenyl)-1-[2-hydroxy-6-methoxy-4-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxyphenyl]prop-2-en-1-one Chemical compound C1=C(O)C(OC)=CC=C1\C=C\C(=O)C(C(=C1)OC)=C(O)C=C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)O1 FDHNLHLOJLLXDH-JIYHLSBYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 206010001488 Aggression Diseases 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- SEBIKDIMAPSUBY-JAUCNNNOSA-N Crocin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C(=O)OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)C=CC=C(/C)C(=O)OC3OC(COC4OC(CO)C(O)C(O)C4O)C(O)C(O)C3O SEBIKDIMAPSUBY-JAUCNNNOSA-N 0.000 description 1
- SEBIKDIMAPSUBY-ARYZWOCPSA-N Crocin Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)C(C)=CC=CC(C)=C\C=C\C=C(/C)\C=C\C=C(C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1)O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SEBIKDIMAPSUBY-ARYZWOCPSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 108010016626 Dipeptides Proteins 0.000 description 1
- 244000166124 Eucalyptus globulus Species 0.000 description 1
- 235000004692 Eucalyptus globulus Nutrition 0.000 description 1
- 108010022355 Fibroins Proteins 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 102000005741 Metalloproteases Human genes 0.000 description 1
- 108010006035 Metalloproteases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 244000047670 Viola x wittrockiana Species 0.000 description 1
- 235000004031 Viola x wittrockiana Nutrition 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000016571 aggressive behavior Effects 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 239000001140 aloe barbadensis leaf extract Substances 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 210000004177 elastic tissue Anatomy 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 230000002431 foraging effect Effects 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical class OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229940087603 grape seed extract Drugs 0.000 description 1
- 235000002532 grape seed extract Nutrition 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 229940076640 hesperidin methylchalcone Drugs 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 229950006238 nadide Drugs 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- MRWXACSTFXYYMV-FDDDBJFASA-N nebularine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC=C2N=C1 MRWXACSTFXYYMV-FDDDBJFASA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 235000003170 nutritional factors Nutrition 0.000 description 1
- 230000037368 penetrate the skin Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 238000011056 performance test Methods 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 239000002212 purine nucleoside Substances 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000037393 skin firmness Effects 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- 230000036548 skin texture Effects 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 230000008833 sun damage Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- 239000011708 vitamin B3 Substances 0.000 description 1
- 239000001717 vitis vinifera seed extract Substances 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
- 235000008210 xanthophylls Nutrition 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
Abstract
The invention discloses a plant anti-wrinkle cosmetic cream and a preparation method thereof, wherein the raw materials comprise the following raw materials in parts by weight: 70-85 parts of water, 0.3-0.5 part of thickening agent, 5-10 parts of oil palm fruit liposome, 2-5 parts of emollient, 0.1-0.5 part of chelating agent, 2-4 parts of emulsifier and 5-10 parts of acetylated resveratrol. The oil palm fruit liposome wraps the effective components in the nano microspheres well, so that the stability of the active components is ensured, and the oil palm fruit liposome is rich in a large amount of fatty acid and vitamin A, E, so that the oil palm fruit liposome can nourish the skin well and remove free radicals. The acetylated resveratrol is more stable and is not easy to decompose, and the excellent oxidation resistance of the acetylated resveratrol and the oil palm fruit liposome have synergistic effect, so that the prepared beauty cream has obvious anti-wrinkle and anti-aging effects.
Description
Technical Field
The invention relates to the technical field of cosmetics, in particular to a plant anti-wrinkle cosmetic cream and a preparation method thereof.
Background
Anti-aging cosmetics have been of constant interest in the cosmetic manufacturing industry, and the focus on the problem of combating skin aging is also a concern. Delaying skin aging is a dream for many people, so the development and application of anti-aging products are an important subject of the cosmetic industry. Skin aging is usually cumulative from two factors: physiological aging and photoaging. Physiological aging is an extremely complex and unavoidable intrinsic process. Some of the reactions that occur during aging include: damage caused by free radicals, collagen destruction, slowed cellular metabolism, abnormal cell formation, decreased fat content, decreased intercellular substance, natural cell death, hormonal dyssecretion, hypoxia, etc. as a result, changes in the skin such as wrinkles, age spots, loss of elasticity, etc. occur. Photoaging is mainly the effect of the environment on the skin, including environmental aggressions, bad living habits, nutritional factors, sun damage, etc. The invasion of the environment is mainly caused by pollution, cold, wind and the like, bad living habits such as smoking and staying up all night and the lack of vitamins (A, E, C, F) or the rarity of other factors (copper, selenium and zinc) are also one of the causes of skin damage; yet another important cause of damage is that under sunlight exposure, ultraviolet rays from the sunlight penetrate the skin and promote the generation of free radicals, causing damage to the skin.
Physiological or photoaging in skin aging can occur in 3 levels: epidermal layer, epidermal-dermal junction layer, and dermal layer. Physiological aging is manifested by thinning of the epidermis, drying, loosening of the epidermis, lack of elasticity, and increased probability of wrinkle formation. Both physiological and photoaging show a weakening of the dermal-epidermal junction, loss of its deep-level supporting function and relaxation. The loosening of the epidermal-dermal junction results in an increased probability of wrinkle formation. It was observed that the adhesion at the interface of the epidermal layer and the dermal layer was decreased, and a barrier to water exchange between the epidermis and the dermis was observed. The dermis is mainly composed of fibroblasts and is responsible for synthesizing proteins (collagen and elastin), proteoglycans (hyaluronic acid), and the like. A structurally complex protein network tissue formed by proteoglycan colloids, collagen fibers, elastic fibers and other proteins are interwoven like fibers to form a tissue structure called extracellular matrix (ECM) in which new cells are produced. Wherein the collagen gives the skin strength and firmness, and the elastin gives the skin elastin polysaccharide (hyaluronic acid) to lock water molecules and form colloid, just like the water reservoir of the skin. Aging reduces the synthesis of collagen and elastin in the skin, thins the dermis, changes its structure, resulting in loss of length and elasticity, and weakens the skin and is more vulnerable to inflammation and free radical attack. The skin loses elasticity and is more vulnerable to allergy and radiation.
At present, researchers believe that the greatest changes in skin result from aging of the dermis layer and most importantly, the reason for aging of the dermis layer is found out. The normal function of the dermal layer results from the balance of (1) macromolecular connective tissue, such as hyaluronic acid, collagen and elastin, and proteases that degrade such macromolecular connective tissue; (2) human neutral elastase, degenerated elastin; (3) a specific enzyme, known as Matrix Metalloproteinase (MMPS), degrades the extracellular matrix. The balance of these specific activity inhibitors of destructive enzymes, termed tissue inhibitors of metalloproteinases, includes many physiological functions, recovery, cell adhesion, cell proliferation, differentiation of cells. In normal skin, there is a balance between the levels of degenerative enzymes such as elastase or matrix metalloproteinase and their inhibitors such as Tissue Inhibitor of Metalloproteinase (TIMPS). I.e. synthesis is equivalent to degeneration. Inflammation, aging and ultraviolet rays disturb the balance between degrading enzymes and their inhibitors leading to excessive degradation of the extracellular matrix. Collagenase (one of MMPS) and elastase destroy collagen and elastin that maintain skin elasticity and firmness, and the structure of skin is also destroyed. The quantification and the keratinization of the extracellular matrix lead to the loss of firmness of the skin and the formation of wrinkles in the dermis, a process that gradually occurs. With the continuous study of wrinkle formation, anti-wrinkle materials have been developed. Materials that can repair the skin barrier, scavenge free radicals, inhibit the activity of matrix metalloproteinases, protect fibroblasts, and promote collagen synthesis are constantly being explored.
The anti-wrinkle raw materials studied at present include the following: (1) peptides: peptides are constituent fragments of protein structures, which are composed of amino acids with a certain sequence, which are linked by an amide bond, and two amino acidsPeptides consisting of amino acids are called dipeptides, peptides consisting of 3 amino acids are called tripeptides, and so on. Compared with other substances in organisms, the peptide has the greatest characteristics of rapid skin penetration and high biological activity, and can realize remarkable skin tendering and anti-wrinkle effects in a short time. (2) Vitamins: vitamin a, also known as retinol, is a lipid-soluble alcohol. Retinol not only promotes the formation of dermal collagen, but also increases the formation of elastin fibers; nicotinamide also known as vitamin B3Is a water-soluble vitamin. It is the main coenzyme for the synthesis of nicotinamide adenine dinucleotide phosphate (NAD). Nicotinamide increases Histone Acetyltransferase (HAT) activity in human fibroblasts while decreasing HAT and histone H4 levels in senescent cells i.e. nicotinamide reverses the phenotypic modulation of senescent fibroblasts by histones; vitamin E is also called tocopherol, can promote metabolism and improve skin elasticity, and has a decisive effect on preventing the skin from being damaged by free radicals; vitamin C, also known as ascorbic acid, is strong in oxidation resistance, but unstable, does not easily enter cells, and can damage intracellular DNA at a large dose. Vitamins E and C have a synergistic effect in scavenging free radicals. (3) Adenosine is a natural purine nucleoside and can be obtained by Adenosine Triphosphate (ATP) decomposition. It was found that adenosine may have a beneficial effect on dynamic wrinkles. (4) The plant active ingredients are as follows: comprises pericarpium Granati, green tea, Eucalyptus globulus, stigma croci Sativi, flos Sophorae Immaturus, etc., and gallic acid derivatives, crocin, flavonoids, etc. contained in these plants have good antioxidant effect, and can also be used for treating OH, O 2Free radicals have good cleaning ability, so the free radicals are widely applied to anti-aging cosmetics. And because the plant components have the characteristics of nature, mildness, no irritation and high safety, the plant components become more and more important for research in recent years.
Patent CN 108324642A discloses an anti-wrinkle repair cream without chemical emulsifier and a preparation method thereof, the anti-wrinkle repair cream comprises the following raw materials in parts by weight: 20-30 parts of oat glucan, 12-20 parts of ceramide, 8-12 parts of resveratrol, 15-25 parts of jojoba oil, 1-5 parts of hydrolyzed collagen, 1.5-3.5 parts of soft and moist conditioning components, 3-7 parts of repair factors, 0.5-2.5 parts of antibacterial components and 15-20 parts of solvent. The anti-wrinkle repair cream disclosed by the invention is mild and harmless in raw materials, high in safety, free of chemical emulsifier and harmless to human skin health, and by taking oat glucan, ceramide, resveratrol and jojoba oil as main frames, the damaged skin can be effectively repaired, fine wrinkles can be smoothed, the skin elasticity can be improved, the skin texture can be improved, and the transdermal absorption performance, the repair performance and the moisturizing performance of the anti-wrinkle repair cream can be improved.
Patent CN 112587435A discloses an eye cream for efficiently repairing fine wrinkles, which comprises the following raw materials by weight: the traditional Chinese medicine composition comprises, by weight, 5 parts of squalane, 1 part of grape seed extract, 2 parts of trehalose, 1 part of fibroin, 1 part of aloe leaf extract, 0.5 part of micromolecular chitosan, 6 parts of glycerol, 1 part of pansy, 5 parts of hexapeptide, 1 part of vitamin complex, 1 part of hesperidin methyl chalcone, 1 part of hyaluronic acid, 1 part of mica, 12 parts of polyhydric alcohol, 12 parts of rose hydrosol, 1 part of antibacterial agent, 45 parts of water, 1 part of emulsifier, 12 parts of jojoba oil, 2 parts of resveratrol, 1 part of lecithin and 0.5 part of preservative. The eye cream is prepared from multiple raw materials, and has the effects of delaying aging and eliminating fine wrinkles; the compound vitamins are matched with each other, so that the anti-wrinkle repairing effect is better. Contains multiple repairing components to activate skin cells, promote the regeneration of horny interstitial substance and accelerate the renewal of eye surrounding cells.
Although plant active ingredients such as resveratrol and the like adopted in the prior art have good anti-aging effect, the stability is poor, and the resveratrol is easy to decompose or hydrolyze under illumination, so that the effect of the prepared anti-wrinkle product is greatly reduced, and the use and popularization of the product are influenced. Therefore, the plant anti-wrinkle cosmetic cream with good anti-wrinkle effect and stable property has great market application value.
Disclosure of Invention
In view of the above defects in the prior art, the technical problem to be solved by the present invention is to prepare a plant anti-wrinkle cosmetic cream with good anti-wrinkle effect and stable properties.
The technical scheme of the invention is as follows:
a preparation method of plant anti-wrinkle cosmetic cream comprises the following steps:
s1, weighing 100-120 parts by weight of oil palm fruits, cleaning, removing seeds, crushing, adding 150-200 parts by weight of 80-90% by volume of ethanol solution, soaking for 20-24 hours, filtering to obtain grease, adding 50-80 parts by weight of 80-90% by volume of ethanol solution, extracting twice, combining the extracts, concentrating at 45-50 ℃ and 0.07-0.09 MPa to dryness to obtain an oil palm fruit extract;
s2, weighing 6-8 parts by weight of the oil palm fruit extract obtained in the step S1, mixing with 0.3-0.5 part by weight of glyceryl monostearate, heating to 70-80 ℃, uniformly stirring, weighing 1-2 parts by weight of Tween 80 and 1-2 parts by weight of span 80, adding into 80-90 parts by weight of water, uniformly stirring, adding into the mixed solution of the oil palm fruit extract, and homogenizing at 70-80 ℃ at 15000-18000 r/min for 15-20 min to obtain oil palm fruit liposome;
S3, weighing 50-60 parts by weight of resveratrol, adding 35-45 parts by weight of pyridine and 1-2 parts by weight of 4-dimethylaminopyridine, dropwise adding 30-50 parts by weight of acetic anhydride, stirring at 25-30 ℃ for 4-6 hours, pouring the mixture into 50-60 parts by weight of ice water, stirring for 5-10 minutes until precipitation appears, and filtering to obtain acetylated resveratrol;
s4, weighing 70-85 parts by weight of water, adding 0.3-0.5 part by weight of thickening agent, and uniformly stirring to obtain a dispersion liquid;
s5, weighing 5-10 parts by weight of oil palm fruit liposome, 2-5 parts by weight of emollient and 0.1-0.5 part by weight of chelating agent, adding into the dispersion liquid obtained in the step S4, heating to 60-70 ℃, and homogenizing at 3000-3500 r/min for 3-5 min;
s6, weighing 2-4 parts by weight of emulsifier, adding the emulsifier into the mixture obtained in the step S4, and homogenizing at 3000-3500 r/min for 3-5 min;
s7, when the temperature of the mixture in the step S6 is reduced to 20-30 ℃, adding 5-10 parts by weight of the resveratrol in the step S3, and homogenizing at 3000-3500 r/min for 3-5 min to obtain the plant anti-wrinkle beauty cream.
The thickener is at least one of carbomer, hydroxyethyl cellulose and 1, 3-propylene glycol.
The emollient is at least one of squalane, glycerol and sodium hyaluronate.
The chelating agent is at least one of ethylenediamine tetraacetic acid, ethylenediamine tetraacetic acid disodium salt and citric acid.
The emulsifier is at least one of tween 80, span 80 and palmityl alcohol.
Compared with the prior art, the invention has the following beneficial effects:
(1) the oil palm fruit liposome is prepared by adopting a thermal homogenization method, and the active ingredients in the oil palm fruit liposome are well wrapped in the nano microspheres, so that the stability of the active ingredients is ensured;
(2) the oil palm fruit extract is rich in a large amount of fatty acid, vitamin A and vitamin E, can well nourish the skin, can remove free radicals, and has a good anti-wrinkle effect;
(3) the resveratrol is more stable and not easy to decompose under the conditions of illumination and water existence, and the excellent inoxidizability of the resveratrol can whiten the skin and resist cell aging, and the resveratrol and the oil palm fruit liposome act synergistically, so that the prepared beauty cream has obvious anti-aging effect.
The invention also provides a plant anti-wrinkle cosmetic cream prepared by the method.
Detailed Description
Hereinafter, the technical solution of the present invention will be described in detail by specific examples, but these examples should be explicitly proposed for illustration, but should not be construed as limiting the scope of the present invention.
The parameters of part of the raw materials in the embodiment of the invention are as follows:
oil palm fruit, production area: yunnan Xishuangbanna.
Comparative example 1
The preparation method of the plant anti-wrinkle cosmetic cream comprises the following steps:
s1 weighing 120g of oil palm fruits, cleaning, removing seeds, crushing, adding 200mL of 90% ethanol solution by volume fraction, soaking for 24h, filtering to obtain grease, adding 60mL of 90% ethanol solution by volume fraction, extracting twice, combining the extracts, and concentrating at 50 ℃ and 0.09MPa to dryness to obtain an oil palm fruit extract;
s2, weighing 6g of the oil palm fruit extract obtained in the step S1, mixing the oil palm fruit extract with 0.5g of glyceryl monostearate, heating the mixture to 75 ℃, uniformly stirring the mixture, weighing 1g of Tween 80 and 1g of span 80, adding the mixture into 90mL of water, uniformly stirring the mixture, adding the mixture into the mixed solution of the oil palm fruit extract, and homogenizing the mixture at 75 ℃ for 15min at 18000r/min to obtain oil palm fruit liposome;
s3 weighing 80g of water, adding 0.3g of 1, 3g of propylene glycol, and stirring uniformly to obtain a dispersion;
s4, weighing 5g of oil palm fruit liposome, 2g of squalane and 0.1g of EDTA-2Na, adding into the dispersion liquid obtained in the step S3, heating to 70 ℃, and homogenizing at 3500r/min for 3 min;
s5, weighing 2g of palmityl alcohol, adding the palmityl alcohol into the mixture obtained in the step S4, and homogenizing at 3500r/min for 3 min;
S6, when the temperature of the mixture is reduced to 20 ℃ in the step S5, 10g of resveratrol is added, and the mixture is homogenized for 3min under the condition of 3500r/min, so that the plant anti-wrinkle cosmetic cream is obtained.
Example 1
A preparation method of plant anti-wrinkle cosmetic cream comprises the following steps:
s1 weighing 120g of oil palm fruits, cleaning, removing seeds, crushing, adding 200mL of 90% ethanol solution by volume fraction, soaking for 24h, filtering to obtain oil, adding 60mL of 90% ethanol solution by volume fraction, extracting twice, combining the extracts, and concentrating at 50 ℃ and 0.09MPa to dryness to obtain an oil palm fruit extract;
s2, weighing 6g of the oil palm fruit extract obtained in the step S1, mixing the oil palm fruit extract with 0.5g of glyceryl monostearate, heating the mixture to 75 ℃, uniformly stirring the mixture, weighing 1g of Tween 80 and 1g of span 80, adding the mixture into 90mL of water, uniformly stirring the mixture, adding the mixture into the mixed solution of the oil palm fruit extract, and homogenizing the mixture at 75 ℃ for 15min at 18000r/min to obtain oil palm fruit liposome;
s3, weighing 60g of resveratrol, adding 45g of pyridine and 30g of 4-dimethylaminopyridine, dropwise adding 45g of acetic anhydride, stirring at 25 ℃ for 6 hours, pouring the mixture into 60mL of ice water, stirring for 10min until a precipitate appears, filtering, and taking the precipitate to obtain the acetylated resveratrol;
s4, weighing 80g of water, adding 0.3g of 1, 3-propylene glycol, and uniformly stirring to obtain a dispersion liquid;
S5, weighing 5g of oil palm fruit liposome, 2g of squalane and 0.1g of EDTA-2Na, adding into the dispersion liquid obtained in the step S4, heating to 70 ℃, and homogenizing at 3500r/min for 3 min;
s6, weighing 2g of palmityl alcohol, adding the palmityl alcohol into the mixture obtained in the step S5, and homogenizing for 3min under the condition of 3500 r/min;
s7, when the temperature of the mixture in the step S6 is reduced to 20 ℃, adding 10g of the resveratrol obtained in the step S3, and homogenizing for 3min under the condition of 3500r/min to obtain the plant anti-wrinkle cosmetic cream.
Example 2
The preparation method of the plant anti-wrinkle cosmetic cream comprises the following steps:
s1 weighing 120g of oil palm fruits, cleaning, removing seeds, crushing, adding 200mL of 90% ethanol solution by volume fraction, soaking for 24h, filtering to obtain oil, adding 60mL of 90% ethanol solution by volume fraction, extracting twice, combining the extracts, and concentrating at 50 ℃ and 0.09MPa to dryness to obtain an oil palm fruit extract;
s2, weighing 60g of resveratrol, adding 45g of pyridine and 30g of 4-dimethylamino pyridine, stirring at 25 ℃ for 6 hours, pouring the mixture into 60mL of ice water, stirring for 10min until a precipitate appears, filtering, and taking the precipitate to obtain the resveratrol;
s3 weighing 80g of water, adding 0.3g of 1, 3-propanediol, and stirring uniformly to obtain a dispersion liquid;
S4, weighing 5g of oil palm fruit extract, 2g of squalane and 0.1g of EDTA-2Na, adding into the dispersion liquid obtained in the step S3, heating to 70 ℃, and homogenizing at 3500r/min for 3 min;
s5, weighing 2g of palmityl alcohol, adding the palmityl alcohol into the mixture obtained in the step S4, and homogenizing for 3min under the condition of 3500 r/min;
s6, when the temperature of the mixture in the step S5 is reduced to 20 ℃, adding 10g of the resveratrol obtained in the step S2, and homogenizing for 3min under the condition of 3500r/min to obtain the plant anti-wrinkle cosmetic cream.
Example 3
The preparation method of the plant anti-wrinkle cosmetic cream comprises the following steps:
s1 weighing 120g of oil palm fruits, cleaning, removing seeds, crushing, adding 200mL of 90% ethanol solution by volume fraction, soaking for 24h, filtering to obtain grease, adding 60mL of 90% ethanol solution by volume fraction, extracting twice, combining the extracts, and concentrating at 50 ℃ and 0.09MPa to dryness to obtain an oil palm fruit extract;
s2 weighing 2000g of xanthoceras spinosa leaves, cleaning, crushing, soaking in 5000mL of ethyl acetate for 24h, filtering, and concentrating the filtrate at 50 ℃ and 0.09MPa to dryness to obtain the xanthoceras spinosa leaf extract;
s3, weighing 60g of resveratrol, adding 45g of pyridine and 30g of 4-dimethylamino pyridine, dropwise adding 100g of the xanthophyll extract in the step S2, stirring at 25 ℃ for 6 hours, pouring the mixture into 60mL of ice water, stirring for 10min until precipitates appear, and filtering to obtain an ursolic acid-resveratrol compound;
S4 weighing 80g of water, adding 0.3g of 1, 3-propanediol, and stirring uniformly to obtain a dispersion liquid;
s5, weighing 5g of oil palm fruit extract, 2g of squalane and 0.1g of EDTA-2Na, adding into the dispersion liquid obtained in the step S4, heating to 70 ℃, and homogenizing at 3500r/min for 3 min;
s6, weighing 2g of palmityl alcohol, adding the palmityl alcohol into the mixture obtained in the step S5, and homogenizing for 3min under the condition of 3500 r/min;
s7, when the temperature of the mixture in the step S6 is reduced to 20 ℃, adding 10g of ursolic acid-resveratrol compound in the step S3, and homogenizing for 3min under the condition of 3500r/min to obtain the plant anti-wrinkle beauty cream.
Test example 1
The control examples and the embodiment are tested for wrinkle removing performance, the test method refers to a T/ZHCA006-2019 cosmetic wrinkle resisting efficacy test method for testing, 80 volunteers are selected, the body is healthy (30-65 years old) and the skin condition is good, the selected volunteers are divided into 4 groups, 20 people in each group are female, and the face of each group has no obvious red, skin damage, scar and the like. Before using the product, images of wrinkles in the sample application area and the control area of the subject are collected, and the total volume value of wrinkles at different positions is analyzed by using analysis software. The test area is coated with complete coverage, and the control area is coated with glycerol solution. Respectively trying the products in the comparative examples and the embodiments, using the products once after cleaning faces in the morning and evening, and after 14 days of use, using the products again And secondly, acquiring wrinkle images of the smearing area and the control area of the sample of the subject, analyzing the total volume values of wrinkles at different positions by using analysis software, calculating the difference value before and after the test, and calculating the relative change rate of the wrinkles according to the formula: (Δ V)Control-ΔVSample (I))/ΔVControl100% relative rate of change of wrinkles. Specific results are shown in table 1.
ΔVSample (I)=(V0-Vt)
In the formula:
ΔVsample (I)Average of the difference in total volume of wrinkles on the side of the sample applied, in cubic millimeters (mm)3);
V0Average value of initial value of total volume of wrinkles on sample application side, in cubic millimeters (mm)3);
VtAverage of the measurements of the total volume of wrinkles measured at various points in time on the applied side of the sample, in cubic millimeters (mm) after application3)。
ΔVControl=(Vr0-Vrt)
In the formula:
ΔVcontrolAverage of the difference in total volume of the wrinkles on the control side, in cubic millimeters (mm)3);
Vr0Average unit of initial value of total volume of wrinkles on control side in cubic millimeters (mm)3);
VrtAverage of the total volume measurements in cubic millimeters (mm) of the control side wrinkles at different measurement time points after sample application3)。
TABLE 1 wrinkle-REMOVING PERFORMANCE TEST RESULTS TABLE
Experimental protocol | Relative rate of change of wrinkles |
Comparative example 1 | 22.3% |
Example 1 | 31.4% |
Example 2 | 14.1% |
Example 3 | 36.4% |
As can be seen from the results in Table 1, the anti-wrinkle cosmetic cream prepared by the invention has certain wrinkle removing effect, has a certain wrinkle eliminating effect, and the examples 1 and 3 show better wrinkle eliminating performance than the comparative examples 1 and 2, this is probably because resveratrol is not easily decomposed and inactivated by subjecting resveratrol to acetylation treatment in example 1, and further can exert good effect when a subject uses the resveratrol-containing extract, the xanthoceras spinosa leaf extract and the resveratrol are adopted to react in the embodiment 3, the ursolic acid rich in the xanthoceras spinosa leaf and the resveratrol are subjected to acylation reaction, the components are more stable after the two are combined, the two can act synergistically when in use, the ursolic acid has good inhibition effect on tyrosinase and elastase, resveratrol has a good anti-oxidation effect, and the combined action of the resveratrol and the anti-oxidation agent results in the best wrinkle removing effect of the product in example 3. In contrast to example 2, the comparative example 1 shows a better wrinkle-removing effect because the oil palm fruit extract is lipidated and the active ingredients are successfully encapsulated in the liposome, and the inactivation of the active ingredients is also avoided.
Test example 2
The control example and the example were subjected to a product mildness test, the test method was referred to GB/T21608-. Sensitization experiments were performed by applying the test article to each group of animals on days 1, 7, and 14. The reaction at the site of application was visually observed and recorded immediately after removal of the drug, followed by 24, 48 and 72 hours after administration, and the skin condition of each group of animals was recorded 14 days later. The specific results are shown in Table 2.
TABLE 2 table of results of the mildness test
Experimental protocol | Condition of the skin |
Comparative example 1 | No obvious abnormality is seen |
Example 1 | No obvious abnormality is seen |
Example 2 | No obvious abnormality is seen |
Example 3 | No obvious abnormality is seen |
It is important that cosmetics have mild properties and are not irritating if they have a certain market value, and products based on plant materials are also preferred for this reason. However, the components in the plant extract are complex and still have the possibility of sensitization, so that the plant extract is very important for carrying out sensitization experiments on products. As can be seen from Table 2, the products prepared by the invention are not irritant, do not cause skin allergic reaction, and are suitable for most people.
Test example 3
The stability tests were performed on the comparative examples and comparative examples, and the test standards were performed on the standards in the cosmetic stability test guideline T/SHFCA 002-2021. The method specifically comprises the steps of circularly placing samples for 7 days at a temperature of 54 ℃, a relative humidity of 75 percent and a light-tight condition, and at a temperature of about-5 ℃ and in a light-tight condition, carrying out heat-resistant and cold-resistant alternative experiments, and respectively detecting the properties, the coating uniformity and whether the layering phenomenon exists in the samples. Specific results are shown in Table 3.
TABLE 3 stability test results
In the stability test, the property of the product changes or the product is layered under extreme conditions due to the property of the product, which can cause the cosmetic cream to lose efficacy and even deteriorate. The results in table 3 show that the loss of the effective components is accelerated under extreme conditions, so that the product is layered and even the properties of the product are changed, which not only causes the function loss and is more likely to cause adverse reactions such as allergy and the like when the product is used by consumers. In examples 1 and 3, the active ingredients of plants were protected, and thus the plant-derived active ingredients were not easily deteriorated and their properties were maintained even under extreme conditions such as low temperature, high temperature, and high humidity. This is probably because the encapsulated nanoparticles formed in the liposome of oil palm fruit in example 1 protect the active ingredients well, and the acetylation of resveratrol makes it not easy to be decomposed, and the ursolic acid-resveratrol complex in example 3 is linked by chemical bonds to make the ingredients more stable, so both can maintain good properties in the stability experiment.
Claims (6)
1. The plant anti-wrinkle cosmetic cream is characterized by comprising the following raw materials in parts by weight: 70-85 parts of water, 0.3-0.5 part of thickening agent, 5-10 parts of oil palm fruit liposome, 2-5 parts of emollient, 0.1-0.5 part of chelating agent, 2-4 parts of emulsifier and 5-10 parts of acetylated resveratrol.
2. The plant anti-wrinkle cosmetic cream as claimed in claim 1, wherein: the thickener is at least one of carbomer, hydroxyethyl cellulose and 1, 3-propylene glycol.
3. The plant anti-wrinkle cosmetic cream according to claim 1, wherein; the emollient is at least one of squalane, glycerol and sodium hyaluronate.
4. The plant anti-wrinkle cosmetic cream according to claim 1, wherein: the chelating agent is at least one of ethylenediamine tetraacetic acid, ethylenediamine tetraacetic acid disodium salt and citric acid.
5. The plant anti-wrinkle cosmetic cream according to claim 1, wherein: the emulsifier is at least one of tween 80, span 80 and palmityl alcohol.
6. The method for preparing the plant anti-wrinkle cosmetic cream according to any one of claims 1 to 5, comprising the steps of:
s1, weighing 100-120 parts by weight of oil palm fruits, cleaning, removing seeds, crushing, soaking in 150-200 parts by weight of 80-90% ethanol solution by volume fraction for 20-24 hours, filtering to obtain grease, adding 50-80 parts by weight of 80-90% ethanol solution by volume fraction for extraction twice, combining the extracts, concentrating at 45-50 ℃ and 0.07-0.09 MPa to dryness to obtain an oil palm fruit extract;
S2, weighing 6-8 parts by weight of the oil palm fruit extract obtained in the step S1 and 0.3-0.5 part by weight of glyceryl monostearate, mixing, heating to 70-80 ℃, uniformly stirring, weighing 1-2 parts by weight of Tween 80 and 1-2 parts by weight of span 80, adding into 80-90 parts by weight of water, uniformly stirring, adding into the mixed solution of the oil palm fruit extract, and homogenizing at 70-80 ℃ at 15000-18000 r/min for 15-20 min to obtain oil palm fruit liposome;
s3, weighing 50-60 parts by weight of resveratrol, adding 35-45 parts by weight of pyridine and 1-2 parts by weight of 4-dimethylaminopyridine, dropwise adding 30-50 parts by weight of acetic anhydride, stirring at 25-30 ℃ for 4-6 hours, pouring the mixture into 50-60 parts by weight of ice water, stirring for 5-10 minutes until precipitates appear, filtering, and taking the precipitates to obtain acetylated resveratrol;
s4, weighing 70-85 parts by weight of water, adding 0.3-0.5 part by weight of thickening agent, and uniformly mixing to obtain a dispersion liquid;
s5, weighing 5-10 parts by weight of oil palm fruit liposome, 2-5 parts by weight of emollient and 0.1-0.5 part by weight of chelating agent, adding into the dispersion liquid obtained in the step S4, and heating to 60-70 ℃ to homogenize at 3000-3500 r/min for 3-5 min;
s6, weighing 2-4 parts by weight of emulsifier, adding the emulsifier into the mixture obtained in the step S5, and homogenizing for 3-5 min at 3000-3500 r/min;
S7, when the temperature of the mixture in the step S6 is reduced to 20-30 ℃, adding 5-10 parts by weight of the resveratrol obtained in the step S3, and homogenizing at 3000-3500 r/min for 3-5 min to obtain the plant anti-wrinkle beauty cream.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210309701.8A CN114748399A (en) | 2022-03-28 | 2022-03-28 | Plant anti-wrinkle cosmetic cream and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210309701.8A CN114748399A (en) | 2022-03-28 | 2022-03-28 | Plant anti-wrinkle cosmetic cream and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114748399A true CN114748399A (en) | 2022-07-15 |
Family
ID=82326792
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210309701.8A Pending CN114748399A (en) | 2022-03-28 | 2022-03-28 | Plant anti-wrinkle cosmetic cream and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114748399A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114886825A (en) * | 2022-04-29 | 2022-08-12 | 深圳润邦之家生物科技有限公司 | Sun-screening wrinkle-removing beauty cream and preparation method thereof |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1804923A1 (en) * | 2004-10-25 | 2007-07-11 | Coty Prestige Lancaster Group GmbH | Moisture-regulating cosmetic |
CN104116876A (en) * | 2013-04-26 | 2014-10-29 | 株式会社海玛特 | Angiogenesis inhibitor, cosmetic, medicine, crystallized haematochrome, foodstuff and manufacturing methods of all |
EP2859882A1 (en) * | 2013-10-10 | 2015-04-15 | Aulive NV | Natural skin care composition |
CN104546613A (en) * | 2015-01-20 | 2015-04-29 | 王雪林 | Mineral-plant nanometer facial mask |
CN104994831A (en) * | 2013-01-22 | 2015-10-21 | 国立庆北大学校产学协力团 | Use of a resveratrol derivative for skin whitening |
CN108324642A (en) * | 2018-03-30 | 2018-07-27 | 广东巴松那生物科技有限公司 | A kind of crease-resistant reparation cream and preparation method thereof without chemical emulsifier |
CN108342251A (en) * | 2018-05-08 | 2018-07-31 | 深圳市仙迪化妆品有限公司 | One seed pod oil and the preparation method and application thereof |
JP2019065004A (en) * | 2017-09-28 | 2019-04-25 | 日光ケミカルズ株式会社 | Skin normal flora improving agent and cosmetic or skin external preparation containing the same |
-
2022
- 2022-03-28 CN CN202210309701.8A patent/CN114748399A/en active Pending
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1804923A1 (en) * | 2004-10-25 | 2007-07-11 | Coty Prestige Lancaster Group GmbH | Moisture-regulating cosmetic |
CN104994831A (en) * | 2013-01-22 | 2015-10-21 | 国立庆北大学校产学协力团 | Use of a resveratrol derivative for skin whitening |
CN104116876A (en) * | 2013-04-26 | 2014-10-29 | 株式会社海玛特 | Angiogenesis inhibitor, cosmetic, medicine, crystallized haematochrome, foodstuff and manufacturing methods of all |
EP2859882A1 (en) * | 2013-10-10 | 2015-04-15 | Aulive NV | Natural skin care composition |
CN104546613A (en) * | 2015-01-20 | 2015-04-29 | 王雪林 | Mineral-plant nanometer facial mask |
JP2019065004A (en) * | 2017-09-28 | 2019-04-25 | 日光ケミカルズ株式会社 | Skin normal flora improving agent and cosmetic or skin external preparation containing the same |
CN108324642A (en) * | 2018-03-30 | 2018-07-27 | 广东巴松那生物科技有限公司 | A kind of crease-resistant reparation cream and preparation method thereof without chemical emulsifier |
CN108342251A (en) * | 2018-05-08 | 2018-07-31 | 深圳市仙迪化妆品有限公司 | One seed pod oil and the preparation method and application thereof |
Non-Patent Citations (1)
Title |
---|
WARANYA NEIMKHUM, 等: "Effects of Carissa carandas Linn. Fruit, Pulp, Leaf, and Seed on Oxidation, Inflammation, Tyrosinase, Matrix Metalloproteinase, Elastase, and Hyaluronidase Inhibition", 《ANTIOXIDANTS》, vol. 10, no. 9, pages 3 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114886825A (en) * | 2022-04-29 | 2022-08-12 | 深圳润邦之家生物科技有限公司 | Sun-screening wrinkle-removing beauty cream and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110279638B (en) | Skin care composition for repairing skin and preparation method thereof | |
CN111067816A (en) | Moisturizing and repairing mask containing active polypeptide and preparation method thereof | |
CN111388346A (en) | Freeze-dried powder live mask with vegetable protein and polypeptide formula and preparation method thereof | |
KR101737446B1 (en) | Cosmetic Composition For Skin Moisturizing | |
CN109998937B (en) | Cosmetic series containing glycerol glucoside (alpha GG) and preparation method thereof | |
CN112545955B (en) | Anti-aging repair composition and preparation method and application thereof | |
KR20180115674A (en) | Synergistic extracts of Palmaria palmata and jasmine, compositions comprising them and uses thereof | |
CN115517999B (en) | Anti-aging composition and application thereof in beauty and skin care | |
CN111265460A (en) | Skin barrier repair compositions and uses thereof | |
CN111840176A (en) | A skin caring composition with effects of resisting glycosylation, whitening skin, removing speckle and removing wrinkle, and its application | |
CN115040464A (en) | Essence composition with wrinkle-removing and anti-aging effects and preparation method thereof | |
WO2006134583A1 (en) | Cosmetic compositions containing lingonberry (vaccinium vitis idea) extracts | |
CN114748399A (en) | Plant anti-wrinkle cosmetic cream and preparation method thereof | |
CN111012699A (en) | Antioxidant oil-controlling emulsion containing fucoidan-kelp extract | |
CN114306161B (en) | Anti-aging composition and preparation method and application thereof | |
KR20180124443A (en) | Cosmetic composition for enhancing skin barrier containing extract of Tremella fuciformis fruiting body | |
CN112545970B (en) | Pearl cream for beauty and skin care and preparation method thereof | |
CN111053721B (en) | Silky glowing eye cream and preparation method thereof | |
KR101154772B1 (en) | Cosmetic composition containing the zizyphus jujuba fruit extract and walnut extract for moisturizing effect on the skin | |
CN113730289A (en) | Eye and lip care composition with multiple repairing effects and application thereof | |
CN112402342A (en) | Anti-aging cosmetic additive and preparation method thereof | |
CN112137937A (en) | Active composition with function of delaying skin aging and application thereof | |
CN111195214A (en) | Anti-aging essence and preparation method thereof | |
CN114272165B (en) | Skin-whitening and tightening plant essence skin-care emulsion and preparation method thereof | |
CN110755315A (en) | Water-in-oil gel pigment cream and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |